Related Experiment Video
Updated: May 14, 2026

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses
Published on: February 23, 2024
Construction, characterization, and evaluation of nanosized curdlan sulfate/quaternary ammonium chitosan/CpG ODN
Zuyi Li1, Yuhe Zhang2, Yipan Chen2
1State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China; Shandong College of Traditional Chinese Medicine, Yantai, 264199, Shandong, China.
Abstract:
CpG oligodeoxynucleotides (CpG ODNs), as nucleic acid adjuvants, effectively stimulate humoral and cellular immune responses. However, their clinical application is limited by drawbacks such as susceptibility to nuclease degradation and high negative charge, which impede cellular uptake. Previously, we have confirmed that polyelectrolyte complex nanoparticles composed of curdlan sulfate (CS) and O-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (CS/O-HTCC) could encapsulate negatively charged proteins and enhance their cellular internalization. Hence, in this study, CS/O-HTCC/CpG nanoparticles (C/O/CpG NPs) were prepared by electrostatic adsorption of positively charged CS/O-HTCC NPs with negatively charged CpG ODN and the formulation was optimized. Besides, the immunological activities of C/O/CpG NPs were evaluated both in vitro and in vivo. Moreover, their adjuvant properties and antitumor effects were assessed using ovalbumin (OVA) as a model antigen. The results showed that C/O/CpG NPs were uniformly spherical with a particle size and polydispersity index (PDI) of 119.67 ± 9.07 nm and 0.18 ± 0.01, respectively. C/O/CpG NPs stimulated the activation of antigen-presenting cells, induce antigen-specific cellular and humoral immune responses effectively and showed significant anti-tumor activity. In conclusion, C/O/CpG NPs could be considered as a promising class of adjuvants for tumor vaccines.
More Related Videos
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
08:15In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
Published on: December 9, 2022